Roivant Sciences Ltd. ($ROIV)
Filing Information
| Accession Number | 0001140361-25-047122 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 1, 2026 |
| Document Date | Dec 29, 2025 |
| Document | View SEC Filing |
Transactions
8
Total Shares
9,594,705
Total Value
$110,009,752.39
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Dec 29, 2025 | Exercise/Conversion | 748,358 | $12.68 | $9,489,179.44 | 19,584,905 | Direct | โ | View Details | |
Director | Common Shares | โ | Dec 29, 2025 | Sale | 311,873 | $21.74 | $6,780,119.02 | 19,273,032 | Direct | โ | View Details | |
Director | Common Shares | โ | Dec 29, 2025 | Other Acquisition or Disposition | 436,485 | $21.74 | $9,489,183.90 | 18,836,547 | Direct | โ | View Details | |
Director | Common Shares | โ | Dec 31, 2025 | Exercise/Conversion | 2,449,877 | $12.68 | $31,064,440.36 | 21,286,424 | Direct | โ | View Details | |
Director | Common Shares | โ | Dec 31, 2025 | Sale | 1,018,995 | $21.71 | $22,122,381.45 | 20,267,429 | Direct | โ | View Details | |
Director | Common Shares | โ | Dec 31, 2025 | Other Acquisition or Disposition | 1,430,882 | $21.71 | $31,064,448.22 | 18,836,547 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Dec 29, 2025 | Exercise/Conversion | 748,358 | $0.00 | $0.00 | 555,840 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Dec 31, 2025 | Exercise/Conversion | 2,449,877 | $0.00 | $0.00 | 95,718 | Direct | โ | View Details |